$PPDI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PHARMACEUTICAL PRODUCT DEVELOPMENT INC. Get notifications about new insider transactions in PHARMACEUTICAL PRODUCT DEVELOPMENT INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 17 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.03 | 100 | 3,703 | 8,518,621 | 8.5 M to 8.5 M (0.00 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.02 | 572 | 21,175 | 8,518,721 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.01 | 420 | 15,544 | 8,519,293 | 8.5 M to 8.5 M (0.00 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.00 | 580 | 21,460 | 8,519,713 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.99 | 1,000 | 36,990 | 8,520,293 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.98 | 1,100 | 40,678 | 8,521,293 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.97 | 1,000 | 36,970 | 8,522,393 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.96 | 1,600 | 59,136 | 8,523,393 | 8.5 M to 8.5 M (-0.02 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.95 | 1,500 | 55,425 | 8,524,993 | 8.5 M to 8.5 M (-0.02 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.94 | 397 | 14,665 | 8,526,493 | 8.5 M to 8.5 M (0.00 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.93 | 600 | 22,158 | 8,526,890 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.92 | 1,000 | 36,920 | 8,527,490 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.91 | 1,000 | 36,910 | 8,528,490 | 8.5 M to 8.5 M (-0.01 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.90 | 2,995 | 110,516 | 8,529,490 | 8.5 M to 8.5 M (-0.04 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.89 | 7,283 | 268,670 | 8,532,485 | 8.5 M to 8.5 M (-0.09 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.88 | 2,137 | 78,813 | 8,539,768 | 8.5 M to 8.5 M (-0.03 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.87 | 1,788 | 65,924 | 8,541,905 | 8.5 M to 8.5 M (-0.02 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.86 | 1,452 | 53,521 | 8,543,693 | 8.5 M to 8.5 M (-0.02 %) |
Jun 19 2007 | PPDI | PHARMACEUTICAL PRO ... | MCNEILL JOHN A JR | Director | Gift | G | 0.00 | 1,112 | 0 | 23,883 | 25 K to 23.9 K (-4.45 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.26 | 100 | 3,726 | 8,600,827 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.24 | 300 | 11,172 | 8,600,927 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.23 | 16 | 596 | 8,601,227 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.22 | 84 | 3,126 | 8,601,243 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.21 | 200 | 7,442 | 8,601,327 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.19 | 100 | 3,719 | 8,601,527 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.18 | 100 | 3,718 | 8,601,627 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.17 | 100 | 3,717 | 8,601,727 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.13 | 75 | 2,785 | 8,601,902 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.12 | 125 | 4,640 | 8,601,902 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.10 | 100 | 3,710 | 8,602,027 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.09 | 300 | 11,127 | 8,602,127 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.08 | 200 | 7,416 | 8,602,427 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.07 | 200 | 7,414 | 8,602,627 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.06 | 218 | 8,079 | 8,602,827 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.05 | 569 | 21,081 | 8,603,045 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.04 | 200 | 7,408 | 8,603,614 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.03 | 1,513 | 56,026 | 8,603,814 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.02 | 600 | 22,212 | 8,605,327 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.01 | 600 | 22,206 | 8,605,927 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 37.00 | 2,900 | 107,300 | 8,606,527 | 8.6 M to 8.6 M (-0.03 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.99 | 500 | 18,495 | 8,609,427 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.98 | 1,900 | 70,262 | 8,609,927 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.97 | 1,228 | 45,399 | 8,611,827 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.96 | 1,372 | 50,709 | 8,613,055 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.95 | 1,100 | 40,645 | 8,614,427 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.94 | 1,700 | 62,798 | 8,615,527 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.93 | 2,870 | 105,989 | 8,617,227 | 8.6 M to 8.6 M (-0.03 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.92 | 1,530 | 56,488 | 8,620,097 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.91 | 541 | 19,968 | 8,621,627 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Buy | S | 37.27 | 200 | 7,454 | 8,600,627 | 8.6 M to 8.6 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Option Exercise | M | 34.62 | 20,000 | 692,400 | 40,000 | |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.91 | 100 | 3,691 | 19,943 | 20 K to 19.9 K (-0.50 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.90 | 577 | 21,291 | 20,043 | 20.6 K to 20 K (-2.80 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.89 | 423 | 15,604 | 20,620 | 21 K to 20.6 K (-2.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.88 | 300 | 11,064 | 21,043 | 21.3 K to 21 K (-1.41 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.87 | 2,100 | 77,427 | 21,343 | 23.4 K to 21.3 K (-8.96 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.86 | 2,300 | 84,778 | 23,443 | 25.7 K to 23.4 K (-8.93 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.85 | 3,550 | 130,818 | 25,743 | 29.3 K to 25.7 K (-12.12 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.84 | 2,390 | 88,048 | 29,293 | 31.7 K to 29.3 K (-7.54 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.83 | 1,400 | 51,562 | 31,683 | 33.1 K to 31.7 K (-4.23 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.78 | 1,300 | 47,814 | 33,083 | 34.4 K to 33.1 K (-3.78 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.77 | 700 | 25,739 | 34,383 | 35.1 K to 34.4 K (-2.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.76 | 2,500 | 91,900 | 35,083 | 37.6 K to 35.1 K (-6.65 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.75 | 1,160 | 42,630 | 37,583 | 38.7 K to 37.6 K (-2.99 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.74 | 380 | 13,961 | 38,743 | 39.1 K to 38.7 K (-0.97 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 36.73 | 820 | 30,119 | 39,123 | 39.9 K to 39.1 K (-2.05 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Buy | M | 34.62 | 20,000 | 692,400 | 39,943 | 19.9 K to 39.9 K (+100.29 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.90 | 1,226 | 45,239 | 8,622,168 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.89 | 1,333 | 49,174 | 8,623,394 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.88 | 1,753 | 64,651 | 8,624,727 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.87 | 1,580 | 58,255 | 8,626,480 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.86 | 1,350 | 49,761 | 8,628,060 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.85 | 1,250 | 46,063 | 8,629,410 | 8.6 M to 8.6 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.84 | 1,900 | 69,996 | 8,630,660 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.83 | 2,100 | 77,343 | 8,632,560 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.82 | 1,716 | 63,183 | 8,634,660 | 8.6 M to 8.6 M (-0.02 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.81 | 3,634 | 133,768 | 8,636,376 | 8.6 M to 8.6 M (-0.04 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.80 | 7,650 | 281,520 | 8,640,010 | 8.6 M to 8.6 M (-0.09 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.79 | 5,627 | 207,017 | 8,647,660 | 8.7 M to 8.6 M (-0.07 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.78 | 4,107 | 151,055 | 8,653,287 | 8.7 M to 8.7 M (-0.05 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.77 | 5,544 | 203,853 | 8,657,394 | 8.7 M to 8.7 M (-0.06 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.76 | 6,021 | 221,332 | 8,662,938 | 8.7 M to 8.7 M (-0.07 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.75 | 7,365 | 270,664 | 8,668,959 | 8.7 M to 8.7 M (-0.08 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.74 | 2,736 | 100,521 | 8,676,324 | 8.7 M to 8.7 M (-0.03 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.73 | 2,400 | 88,152 | 8,679,060 | 8.7 M to 8.7 M (-0.03 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.72 | 800 | 29,376 | 8,681,460 | 8.7 M to 8.7 M (-0.01 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.71 | 200 | 7,342 | 8,682,260 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.70 | 100 | 3,670 | 8,682,460 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.69 | 200 | 7,338 | 8,682,560 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.68 | 100 | 3,668 | 8,682,760 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.66 | 100 | 3,666 | 8,682,860 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.65 | 100 | 3,665 | 8,682,960 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.64 | 100 | 3,664 | 8,683,060 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.61 | 100 | 3,661 | 8,683,160 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.58 | 100 | 3,658 | 8,683,260 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.42 | 200 | 7,284 | 8,683,360 | 8.7 M to 8.7 M (0.00 %) |
Jun 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.39 | 400 | 14,556 | 8,683,560 | 8.7 M to 8.7 M (0.00 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 21.19 | 25,000 | 529,750 | 50,000 | |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Option Exercise | M | 15.30 | 13,334 | 204,010 | 0 | |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.26 | 2,600 | 91,676 | 8,781 | 11.4 K to 8.8 K (-22.85 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.28 | 1,200 | 42,336 | 11,381 | 12.6 K to 11.4 K (-9.54 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.27 | 2,800 | 98,756 | 12,581 | 15.4 K to 12.6 K (-18.20 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.24 | 2,800 | 98,672 | 15,381 | 18.2 K to 15.4 K (-15.40 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.23 | 2,800 | 98,644 | 18,181 | 21 K to 18.2 K (-13.35 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.21 | 2,800 | 98,588 | 20,981 | 23.8 K to 21 K (-11.77 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.20 | 10,000 | 352,000 | 23,781 | 33.8 K to 23.8 K (-29.60 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.11 | 13,334 | 468,157 | 33,781 | 47.1 K to 33.8 K (-28.30 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 21.19 | 25,000 | 529,750 | 47,115 | 22.1 K to 47.1 K (+113.05 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Buy | M | 15.30 | 13,334 | 204,010 | 22,115 | 8.8 K to 22.1 K (+151.85 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.13 | 1,050 | 36,887 | 8,781 | 9.8 K to 8.8 K (-10.68 %) |
May 30 2007 | PPDI | PHARMACEUTICAL PRO ... | COVINGTON PAUL S | Executive Vice Pres ... | Sell | S | 35.14 | 700 | 24,598 | 9,831 | 10.5 K to 9.8 K (-6.65 %) |
Jun 04 2007 | PPDI | PHARMACEUTICAL PRO ... | Sharbaugh William J | Chief Operating Off ... | Option Exercise | A | 36.50 | 75,000 | 2,737,500 | 75,000 | |
Jun 04 2007 | PPDI | PHARMACEUTICAL PRO ... | Sharbaugh William J | Chief Operating Off ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.49 | 1,000 | 35,490 | 485,015 | 486 K to 485 K (-0.21 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.48 | 4,200 | 149,016 | 486,015 | 490.2 K to 486 K (-0.86 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.46 | 1,000 | 35,460 | 490,215 | 491.2 K to 490.2 K (-0.20 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.44 | 22,000 | 779,680 | 491,215 | 513.2 K to 491.2 K (-4.29 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.43 | 14,000 | 496,020 | 513,215 | 527.2 K to 513.2 K (-2.66 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.42 | 6,000 | 212,520 | 527,215 | 533.2 K to 527.2 K (-1.13 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.39 | 1,000 | 35,390 | 533,215 | 534.2 K to 533.2 K (-0.19 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.38 | 4,000 | 141,520 | 534,215 | 538.2 K to 534.2 K (-0.74 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.37 | 2,000 | 70,740 | 538,215 | 540.2 K to 538.2 K (-0.37 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.36 | 3,000 | 106,080 | 540,215 | 543.2 K to 540.2 K (-0.55 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.35 | 1,000 | 35,350 | 543,215 | 544.2 K to 543.2 K (-0.18 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.33 | 3,000 | 105,990 | 544,215 | 547.2 K to 544.2 K (-0.55 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.31 | 1,000 | 35,310 | 547,215 | 548.2 K to 547.2 K (-0.18 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.30 | 6,000 | 211,800 | 548,215 | 554.2 K to 548.2 K (-1.08 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.29 | 6,000 | 211,740 | 554,215 | 560.2 K to 554.2 K (-1.07 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.28 | 18,800 | 663,264 | 560,215 | 579 K to 560.2 K (-3.25 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.26 | 3,000 | 105,780 | 579,015 | 582 K to 579 K (-0.52 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.25 | 3,000 | 105,750 | 582,015 | 585 K to 582 K (-0.51 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 35.40 | 1,300 | 46,020 | 19,943 | 21.2 K to 19.9 K (-6.12 %) |
May 25 2007 | PPDI | PHARMACEUTICAL PRO ... | BADDOUR LINDA | Chief Financial Off ... | Sell | S | 35.30 | 6,757 | 238,522 | 21,243 | 28 K to 21.2 K (-24.13 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | KLEMA CATHY | Director | Option Exercise | M | 12.81 | 12,000 | 153,720 | 0 | |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | KLEMA CATHY | Director | Sell | S | 35.46 | 4,900 | 173,754 | 7,215 | 12.1 K to 7.2 K (-40.45 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | KLEMA CATHY | Director | Sell | S | 35.47 | 1,500 | 53,205 | 12,115 | 13.6 K to 12.1 K (-11.02 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | KLEMA CATHY | Director | Sell | S | 35.48 | 4,138 | 146,816 | 13,615 | 17.8 K to 13.6 K (-23.31 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | KLEMA CATHY | Director | Sell | S | 35.49 | 1,462 | 51,886 | 17,753 | 19.2 K to 17.8 K (-7.61 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | KLEMA CATHY | Director | Buy | M | 12.81 | 12,000 | 153,720 | 19,215 | 7.2 K to 19.2 K (+166.32 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.40 | 2,000 | 70,800 | 0 | 2 K to 0 (-100.00 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.39 | 2,000 | 70,780 | 2,000 | 4 K to 2 K (-50.00 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.38 | 3,000 | 106,140 | 4,000 | 7 K to 4 K (-42.86 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.37 | 1,000 | 35,370 | 7,000 | 8 K to 7 K (-12.50 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.36 | 1,168 | 41,300 | 8,000 | 9.2 K to 8 K (-12.74 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.35 | 2,000 | 70,700 | 9,168 | 11.2 K to 9.2 K (-17.91 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.34 | 1,000 | 35,340 | 11,168 | 12.2 K to 11.2 K (-8.22 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.33 | 1,217 | 42,997 | 12,168 | 13.4 K to 12.2 K (-9.09 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.32 | 3,000 | 105,960 | 13,385 | 16.4 K to 13.4 K (-18.31 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.31 | 3,300 | 116,523 | 16,385 | 19.7 K to 16.4 K (-16.76 %) |
May 23 2007 | PPDI | PHARMACEUTICAL PRO ... | MARIO ERNEST | Director | Sell | S | 35.30 | 3,628 | 128,068 | 19,685 | 23.3 K to 19.7 K (-15.56 %) |